Altimmune (ALT)
(Delayed Data from NSDQ)
$6.33 USD
+0.83 (15.09%)
Updated Aug 8, 2024 03:59 PM ET
After-Market: $6.40 +0.07 (1.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: BMO |
6/2024 | $-0.34 | 0.00% |
Earnings Summary
For their last quarter, Altimmune (ALT) reported earnings of -$0.35 per share, missing the Zacks Consensus Estimate of -$0.34 per share. This reflects a negative earnings surprise of 2.94%. Look out for ALT's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.34 per share, reflecting a year-over-year decrease of 6.25%.
Earnings History
Price & Consensus
Zacks News for ALT
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
ALT: What are Zacks experts saying now?
Zacks Private Portfolio Services